Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Directorate Changes

18 Jul 2023 16:31

RNS Number : 4187G
Versarien PLC
18 July 2023
 

18 July 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

Directorate Changes

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce the appointment of Dr Stephen Hodge, currently the Company's Chief Technology Officer, as the Company's Chief Executive Officer with immediate effect.

 

Dr Stephen Hodge joined Versarien in 2017 and was appointed Head of Research in July 2018, before being appointed to the Board as Chief Technology Officer in January 2021. Prior to this, he was employed as a Principal Engineer at Cambridge Graphene Limited, a supplier of graphene inks and other graphene materials, and a subsidiary of Versarien. He has also held post-doctoral research associate positions at the Cambridge Graphene Centre, a research centre attached to the Department of Engineering at the University of Cambridge, and in the Department of Chemistry at Imperial College London, where he also completed a PhD in Nanomaterial Chemistry.

 

Stephen is a member of a number of advisory boards including holding the role of Chairman of the Technical Working Group within the Graphene REACH registration consortium. Last year Dr Hodge was awarded the Royal Society of Chemistry Rising Star in Industry Award 'for strategic leadership in developing greener solutions and advocating for global regulations related to the physical and toxicological testing of graphene'.

 

Resignation of Director

 

The Company has today received confirmation that Neill Ricketts has resigned from the Board with effect from 14 July 2023 and is no longer a Director of the Company. He continues on garden leave with no day-to-day responsibilities unless required by the Company.

 

Diane Savory, Non-executive Chair of Versarien, commented:

 

"I am very pleased that we are announcing the appointment of Stephen Hodge as Versarien's Chief Executive Officer. Stephen has been with Versarien for the past six years during which time he has been instrumental in the development of the Company's advanced materials technology and progressing our commercial relationships. I believe he is ideally placed to lead the Company as we continue to progress our turnaround strategy and focus on the development and commercialisation of Cementene™ and Graphene-Wear™.

 

"On behalf of the Board I would like to thank Neill Ricketts for his contribution to the Company since its formation and we wish him well in his future endeavours.

 

"We look forward to updating shareholders on the continuing progress with our turnaround strategy in the coming months."

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKFBBPBKDFOD
Date   Source Headline
15th Jan 20187:00 amRNSPlanned Chinese graphene manufacturing facility
8th Jan 20187:00 amRNSAgreement with Global Apparel Manufacturer
5th Jan 201811:05 amRNSDirector/PDMR Shareholding
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSExercise of Options
4th Dec 201711:05 amRNSSecond Price Monitoring Extn
4th Dec 201711:00 amRNSPrice Monitoring Extension
4th Dec 20179:00 amRNSPrice Monitoring Extension
4th Dec 20177:00 amRNSAgreement with Global Chemical Major
1st Dec 20172:05 pmRNSSecond Price Monitoring Extn
1st Dec 20172:00 pmRNSPrice Monitoring Extension
29th Nov 20177:00 amRNSInterim Results
28th Nov 20172:05 pmRNSSecond Price Monitoring Extn
28th Nov 20172:00 pmRNSPrice Monitoring Extension
21st Nov 20179:05 amRNSSecond Price Monitoring Extn
21st Nov 20179:00 amRNSPrice Monitoring Extension
17th Nov 20177:00 amRNSCollaboration with Global Consumer Goods Company
7th Nov 20174:40 pmRNSSecond Price Monitoring Extn
7th Nov 20174:35 pmRNSPrice Monitoring Extension
7th Nov 20173:07 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSSuccessful Fundraising of £2.9 million
3rd Nov 20174:43 pmRNSFundraising of approximately £1.2 million
3rd Nov 20174:40 pmRNSTrading Update and Notice of Results
31st Oct 20174:40 pmRNSSecond Price Monitoring Extn
31st Oct 20174:35 pmRNSPrice Monitoring Extension
31st Oct 20172:05 pmRNSSecond Price Monitoring Extn
31st Oct 20172:00 pmRNSPrice Monitoring Extension
31st Oct 20177:00 amRNSCollaboration with Israel Aerospace Industries
2nd Oct 20177:00 amRNSAward of Share Options to Directors
22nd Sep 20171:11 pmRNSDirector/PDMR Shareholding
21st Sep 20179:38 amRNSHolding(s) in Company
20th Sep 20179:00 amRNSHolding(s) in Company
19th Sep 201711:01 amRNSHolding(s) in Company
19th Sep 201711:00 amRNSHolding(s) in Company
19th Sep 20177:00 amRNSSignificant Tender Win
14th Sep 20176:03 pmRNSHolding(s) in Company
13th Sep 201711:45 amRNSResult of AGM
12th Sep 201712:26 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSHolding(s) in Company
11th Sep 20178:09 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSContract Win
1st Sep 20177:00 amRNSHolding(s) in Company
23rd Aug 20173:45 pmRNSHolding(s) in Company
9th Aug 201710:30 amRNSNotice of AGM
3rd Jul 20177:00 amRNSFinal Results for the year ended 31 March 2017
20th Apr 20177:00 amRNSInvestor Event
20th Apr 20177:00 amRNSResignation of Director
6th Apr 201711:13 amRNSHolding(s) in Company
4th Apr 20173:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.